New alliance pushes ESG standards for Vietnamese businesses
A new partnership between EY and the Vietnam-Singapore Board Forum (VSBF) is set to strengthen ESG capabilities for Vietnamese businesses, helping shape more sustainable business models.
The Adamed Group has acquired the controlling portion of shares in Dat Vi Phu Pharmaceutical Co. Ltd (Davipharm), Vietnam’s fastest-growing pharmaceutical company, marking the largest direct Polish investment in Vietnam to-date, according to the information just released by Adamed Group.
Adamed Group has just made an investment amount of US$50 million in Davipharm.
Davipharm manufactures a wide range of medicinal products for both Vietnamese and neighboring markets. “We consider our investment to be a launch pad for the further dynamic expansion of the Adamed Group into the Asia-Pacific region,” said Ph.D. Małgorzata Adamkiewicz, Director General of the Adamed Group.
“I am convinced that, in view of the scale of this transaction and further investments into the development of the company, our undertaking will constitute a milestone in strengthening economic relations between Poland and Vietnam”, Adamkiewicz added.
The deal provides for an extensive investment plan, including the transfer of Adamed’s knowledge and expertise.
In more than 10 years since its establishment, Davipharm has achieved a sizable share of the Vietnamese pharmaceutical market. “The investment by the Adamed Group is an opportunity for our continued dynamic development. Co-operation with such an experienced partner will enable us to reinforce our position in the local market and to expand in the Asia and Pacific region,” said Phạm Tai Truong, Director of Davipharm.
The investment in Vietnam forms part of the internationalization of the Adamed Group. In 2016, the company recorded a 15% increase in export revenues. The Adamed Group aims to constantly increase its foreign sales.
Davipharm – is a Vietnamese company established in 2004, which manufactures nearly 300 medicinal products in most therapeutic classes. It is the fastest-growing company in the Vietnamese pharmaceutical market. It exports its products to the Philippines, Cambodia and Myanmar.
Located in Binh Duong province near Ho Chi Minh City, it currently employs approximately 200 people.
A new partnership between EY and the Vietnam-Singapore Board Forum (VSBF) is set to strengthen ESG capabilities for Vietnamese businesses, helping shape more sustainable business models.
With strategic deals and strong policy alignment from the Vietnamese government, Excelerate Energy aims to anchor Vietnam’s LNG ambitions in the region.
Scheduled for completion in 2027, the logistics facility will be the first of its kind in Vietnam significantly boosting parcel processing capacity up to 7 million parcels daily.
Gamuda Land will use the loan to invest in a luxury real estate project in Ho Chi Minh City.
Amid global economic volatility, WHA Group has rapidly rolled out multiple expansion projects in Vietnam, signaling its strategic focus on the country.
Hai Phong Port JSC. has inaugurated international container terminals No. 3 and 4 at Lach Huyen, raising its throughput capacity to 3.5 million TEUs per year.